home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Iveric Bio Announces the Addition of Global Pharmaceutical Veteran, Christine Ann Miller, to its Board of Directors

January 06, 2022

From Iveric Bio

Via Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 04, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio to Present at the H.C. Wainwright BioConnect Virtual Conference

January 04, 2022

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Appoints Tony Gibney as Executive Vice President and Chief Business and Strategy Officer

December 13, 2021

From IVERIC bio, Inc.

Via Business Wire

7 A-Rated Biotechs to Buy for the Long Run ↗

December 03, 2021

The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples.

Via InvestorPlace

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 02, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio to Participate in the Stifel 2021 Virtual Healthcare Conference

November 10, 2021

From IVERIC bio, Inc.

Via Business Wire

10 Biggest Price Target Changes For Wednesday ↗

November 10, 2021

Needham raised DoorDash, Inc. (NASDAQ:DASH) pric...

Via Benzinga

IVERIC bio, Inc. (ISEE) Q3 2021 Earnings Call Transcript ↗

November 09, 2021

ISEE earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Iveric Bio Reports Third Quarter 2021 Operational Highlights and Financial Results

November 09, 2021

From IVERIC bio, Inc.

Via Business Wire

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Iveric Bio to Participate in the Credit Suisse 30th Annual Virtual Healthcare Conference

November 03, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 02, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio to Report Third Quarter 2021 Financial Results and Host Conference Call on Tuesday, November 9, 2021

November 02, 2021

From IVERIC bio, Inc.

Via Business Wire

The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs ↗

October 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Athira Names Chief Operating Officer Mark Litton As Next CEO as Leen Kawas...

Via Benzinga

Iveric Bio Announces Pricing of Upsized Public Offering of Common Stock

October 21, 2021

From IVERIC bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 21, 2021

Gainers T2 Biosystems (NASDAQ:TTOO) shar...

Via Benzinga

Iveric Bio Announces Proposed Offering of Common Stock

October 21, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 04, 2021

From IVERIC bio, Inc.

Via Business Wire

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive ↗

September 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (...

Via Benzinga

Iveric Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 10, 2021

From IVERIC bio, Inc.

Via Business Wire

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher ↗

September 10, 2021

Toward the end of trading Friday, the Dow traded down 0.31% to 34,772.74 while the NASDAQ fell 0.27% to 15,207.42. The S&P also fell, dropping 0.28% to 4,480.86. The U.S. has...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

8 Health Care Stocks With Unusual Options Alerts In Today's Session ↗

September 10, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Dow Eyes Fifth-Straight Skid, Another Weekly Drop ↗

September 10, 2021

The Dow Jones Industrial Index is giving up its earlier gains, last seen down 149 points, as investors fail to shake off the economic uncertainty that's blanketed the holiday-shortened week.

Via Talk Markets

Topics Stocks

60 Biggest Movers From Friday ↗

September 13, 2021

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 10, 2021

Gainers IVERIC bio (NASDAQ:ISEE) shares increased by 63.11% to $14.18 during Friday's regular session. IVERIC bio's stock is trading at a volume of 120.3 million...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge ↗

September 10, 2021

Midway through trading Friday, the Dow traded down 0.40% to 34,739.37 while the NASDAQ fell 0.06% to 15,238.92. The S&P also fell, dropping 0.21% to 4,483.84. The U.S. has the...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com